Boehringer Ingelheim and partners start clinical development of a first-in-class, inhaled gene therapy for people with cystic fibrosis
Boehringer Ingelheim, IP Group, the UK Respiratory Gene Therapy Consortium (GTC) 1 and OXB, 1 today announce the start of LENTICLAIR TM 1, a Phase I/II trial of BI 3720931, a novel, first-in-class, ...
RBR1h
ENCO Builds AI Ad Creation Into vCreative with SPECai
ENCO has integrated its SPECai ad creation service into vCreative’s media workflow platforms, allowing vCreative users with a ...
Gene Therapy Market to Hit USD 36.55 Billion by 2032 with 19.4% CAGR | MarketsandMarkets™.
The global Gene Therapy market, valued at US$7.21 billion in 2023, is forecasted to grow at a robust CAGR of 19.4%, reaching ...
Gene Therapy Market to Hit USD 36.55 Billion by 2032 with 19.4% CAGR | MarketsandMarkets.
The global Gene Therapy market, valued at US$7.21 billion in 2023, is forecasted to grow at a robust CAGR of 19.4%, reaching US$8.85 billion ...
Analysts Conflicted on These Communication Services Names: MediaAlpha (MAX) and Fiverr International (FVRR)
Companies in the Communication Services sector have received a lot of coverage today as analysts weigh in on MediaAlpha (MAX – Research ...
Vincennes Sun-Commercial18h
A century of journalism; VU's Trailblazer announces redesigned logo
VINCENNES - To celebrate 100 years of journalism on Vincennes University's campus, the College of Social Science, Performing ...